JP2004505899A - ５’−デオキシ−ｎ−（置換されたオキシカルボニル）−５−フルオロシトシン及びその誘導体、その製造方法、並びに、これを有効性分として含む抗癌剤組成物 - Google Patents

５’−デオキシ−ｎ−（置換されたオキシカルボニル）−５−フルオロシトシン及びその誘導体、その製造方法、並びに、これを有効性分として含む抗癌剤組成物 Download PDF

Info

Publication number
JP2004505899A
JP2004505899A JP2002517006A JP2002517006A JP2004505899A JP 2004505899 A JP2004505899 A JP 2004505899A JP 2002517006 A JP2002517006 A JP 2002517006A JP 2002517006 A JP2002517006 A JP 2002517006A JP 2004505899 A JP2004505899 A JP 2004505899A
Authority
JP
Japan
Prior art keywords
group
compound
fluorocytosine
deoxy
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002517006A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004505899A5 (enExample
Inventor
キム　クワン−ヒ
キム　ヨン−チュル
キム　ジ−ヤン
リー　キョン−ホ
ノー　ムーン−ジョン
パク　ヨン−ソク
チョ　スン−ミン
パク　ホ−ジン
Original Assignee
コーロン　インダストリーズ　インク
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020000046179A external-priority patent/KR100730768B1/ko
Priority claimed from KR1020010044193A external-priority patent/KR20030009649A/ko
Application filed by コーロン　インダストリーズ　インク filed Critical コーロン　インダストリーズ　インク
Publication of JP2004505899A publication Critical patent/JP2004505899A/ja
Publication of JP2004505899A5 publication Critical patent/JP2004505899A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2002517006A 2000-08-09 2001-08-08 ５’−デオキシ−ｎ−（置換されたオキシカルボニル）−５−フルオロシトシン及びその誘導体、その製造方法、並びに、これを有効性分として含む抗癌剤組成物 Pending JP2004505899A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020000046179A KR100730768B1 (ko) 2000-08-09 2000-08-09 5'-데옥시-ｎ-알킬옥시카르보닐-5-플루오로사이토신-5'-카르복실산 및 그 유도체와 이들의 제조방법
KR1020010044193A KR20030009649A (ko) 2001-07-23 2001-07-23 Ν-알키닐옥시카르보닐-5-플루오로시토신 유도체, 그제조방법 및 이를 유효성분으로 포함하는 항암제
PCT/KR2001/001351 WO2002011668A2 (en) 2000-08-09 2001-08-08 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients

Publications (2)

Publication Number Publication Date
JP2004505899A true JP2004505899A (ja) 2004-02-26
JP2004505899A5 JP2004505899A5 (enExample) 2005-02-24

Family

ID=26638291

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002517006A Pending JP2004505899A (ja) 2000-08-09 2001-08-08 ５’−デオキシ−ｎ−（置換されたオキシカルボニル）−５−フルオロシトシン及びその誘導体、その製造方法、並びに、これを有効性分として含む抗癌剤組成物

Country Status (5)

Country Link
EP (1) EP1311524A2 (enExample)
JP (1) JP2004505899A (enExample)
CN (1) CN1446225A (enExample)
AU (1) AU2001278804A1 (enExample)
WO (1) WO2002011668A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008010571A1 (fr) * 2006-07-21 2008-01-24 Taiho Pharmaceutical Co., Ltd. Composé nucléosidique de 2'cyanopyrimidine

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101993464B (zh) * 2009-08-19 2014-07-23 成都弘达药业有限公司 一种卡培他滨的制备方法
CN103897004B (zh) * 2012-12-27 2017-05-31 鲁南制药集团股份有限公司 一种卡培他滨的合成方法
EP3452044A4 (en) * 2016-06-28 2020-04-22 Cellix Bio Private Limited COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
EP3618837A4 (en) * 2017-04-26 2020-11-04 Thomas I. Kalman MULTI-DIRECTIONAL NUCLEOSIDE DERIVATIVES
KR20210057025A (ko) * 2018-08-03 2021-05-20 셀릭스 바이오 프라이빗 리미티드 암의 치료를 위한 조성물 및 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
US5276151A (en) * 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5204466A (en) * 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5914331A (en) * 1990-02-01 1999-06-22 Emory University Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008010571A1 (fr) * 2006-07-21 2008-01-24 Taiho Pharmaceutical Co., Ltd. Composé nucléosidique de 2'cyanopyrimidine

Also Published As

Publication number Publication date
WO2002011668A2 (en) 2002-02-14
WO2002011668A3 (en) 2002-04-18
AU2001278804A1 (en) 2002-02-18
EP1311524A2 (en) 2003-05-21
CN1446225A (zh) 2003-10-01

Similar Documents

Publication Publication Date Title
JP2501297B2 (ja) Ｎ４−（置換−オキシカルボニル）−５′−デオキシ−５−フルオロシチジン誘導体
US20110015147A1 (en) Anti-viral pyrimidine nucleoside analogues
JP5087052B2 (ja) 改良された治療剤
JP6769000B2 (ja) ４’−チオヌクレオシドの新規な化合物、並びにその調製方法、その医薬組成物及びその用途
JP2004505899A (ja) ５’−デオキシ−ｎ−（置換されたオキシカルボニル）−５−フルオロシトシン及びその誘導体、その製造方法、並びに、これを有効性分として含む抗癌剤組成物
CN112724088B (zh) 尿嘧啶类化合物及其抗肿瘤用途
RU2347786C2 (ru) Производные сложноэфирных липидов нуклеотидов
KR101426101B1 (ko) 3＇-에티닐시티딘 유도체
SE436208B (sv) Sett att framstella 5-fluoro-uracilderivat
JPS62919B2 (enExample)
KR20030009649A (ko) Ν-알키닐옥시카르보닐-5-플루오로시토신 유도체, 그제조방법 및 이를 유효성분으로 포함하는 항암제
EP1968971B1 (en) Dioxolane derivates for the treatment of cancer
JPH08837B2 (ja) サイクリツクａｍｐ誘導体
KR100730768B1 (ko) 5'-데옥시-ｎ-알킬옥시카르보닐-5-플루오로사이토신-5'-카르복실산 및 그 유도체와 이들의 제조방법
US20030166606A1 (en) 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
CN118063439B (zh) 一种喹唑啉类化合物的制备及用途
KR100631754B1 (ko) Ｎ-알킬옥시카르보닐-5-플루오로사이토신 유도체 및 그의제조방법
JPS6337787B2 (enExample)
CN113336816B (zh) 胞苷类化合物及其抗肿瘤用途
RU2200157C2 (ru) Пиридинкарбоксамидины, способ их получения и фармацевтическая композиция на их основе
KR20030050504A (ko) 신규5'-데옥시-ｎ-알킬옥시카르보닐-5-플루오로사이토신-5'-아미드 유도체, 그의 제조방법, 및 이를 유효성분으로포함하는 항암제
KR20040008410A (ko) 신규5'-데옥시-ｎ-알킬옥시카르보닐-5-플루오로사이토신-5'-티오에스터 유도체, 그의 제조방법, 및 이를 유효성분으로포함하는 항암제
JPWO2008010571A1 (ja) ２’−シアノピリミジンヌクレオシド化合物
KR20030071263A (ko) 1-(4'-비닐-베타-ｄ-에리쓰로노퓨라실)-5-플루오로-ｎ4-(알킬옥시카르보닐)-사이토신 유도체, 그의 제조방법 및 이를유효성분으로 하는 항암제
JP4010814B2 (ja) メバロン酸誘導体

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20061026

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20061031

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070403